Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · IEX Real-Time Price · USD
2.250
+0.010 (0.45%)
At close: Jul 26, 2024, 4:00 PM
2.263
+0.013 (0.58%)
After-hours: Jul 26, 2024, 5:00 PM EDT
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of $155.25 million as of July 26, 2024. Its market cap has increased by 216.83% in one year.
Market Cap
155.25M
Enterprise Value
124.77M
1-Year Change
216.83%
Ranking
Category
Stock Price
$2.25
Market Cap Chart
Since August 10, 2021, Cardiol Therapeutics's market cap has increased from $102.60M to $155.25M, an increase of 51.31%. That is a compound annual growth rate of 15.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 26, 2024 | 144.20M | 164.10% |
| Dec 29, 2023 | 54.60M | 68.52% |
| Dec 30, 2022 | 32.40M | -60.20% |
| Dec 31, 2021 | 81.40M | -20.66% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Compugen | 158.47M |
| Invivyd | 157.50M |
| Quantum-Si incorporated | 157.42M |
| Rani Therapeutics Holdings | 155.93M |
| DiaMedica Therapeutics | 155.58M |
| ProQR Therapeutics | 153.52M |
| aTyr Pharma | 153.20M |
| High Tide | 152.04M |